| | | | | | | | | | |
|
| |
|
| Dockets Entered
On December 22, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
|
|
| 2000N-0504
|
| Egg Safety Action Plan
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
|
|
| 2004D-0369
|
| Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
|
|
|
|
|
| 2004D-0438
|
| Guidance for Industry: Use of Material from BSE-Positive Cattle in Animal Feed
|
|
|
|
|
| 2004D-0440
|
| Guidance for Industry on Computerized Systems Used in Clinical Trials
|
|
|
|
|
| 2004D-0460
|
| Guidance for Industry on Listed Drugs, 30-Month Stays, and Approval of ANDAs and 505(b)(2) Applications Under Hatch-Waxman, as Amended by the Medicare Prescription Drug, Improvement, and Modernization
|
|
|
|
|
|
| 2004N-0081
|
| BSE Risk Materials in Foods and Cosmetics
|
|
|
|
|
| 2004N-0355
|
| Scientific Considerations Related to Developing Follow-on Protein Products
|
|
|
|
|
| 2004P-0223
|
| Whole Grain Descriptive Claims
|
|
|
|
|
| 2004P-0557
|
| ANDA for a generic version of Efudex Cream(fluorouracil) cream
|
|
| |
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
|
|
| RPT
252
|
| Gencor Pacific Inc
|
| Vol #:
|
| 184
|
|
|
|
|
| RPT
253
|
| AIBMR Life Sciences Inc
|
| Vol #:
|
| 185
|
|
|
|
|
| RPT
254
|
| ArtJen Complexus Inc
|
| Vol #:
|
| 186
|
|
|
|
|
| 2000N-0504
|
| Egg Safety Action Plan
|
|
|
|
|
| C 220
|
| S and H Wyck
|
| Vol #:
|
| 19
|
|
|
|
|
| C
221
|
| Js West and Companies
|
| Vol #:
|
| 19
|
|
|
|
|
| C 222
|
| Illegible
|
| Vol #:
|
| 19
|
|
|
|
|
| C
223
|
| Center Fresh Egg Farm, LLP
|
| Vol #:
|
| 19
|
|
|
|
|
| C
224
|
| Larkin Farms
|
| Vol #:
|
| 19
|
|
|
|
|
| C 225
|
| K. Call
|
| Vol #:
|
| 19
|
|
|
|
|
| C 226
|
| C. Wondra
|
| Vol #:
|
| 19
|
|
|
|
|
| C 227
|
| J. Coalgate
|
| Vol #:
|
| 19
|
|
|
|
|
| C 228
|
| A. Sandy
|
| Vol #:
|
| 19
|
|
|
|
|
| C 229
|
| K. Lance
|
| Vol #:
|
| 19
|
|
|
|
|
| C 230
|
| Seniors at St. Thomas More High School
|
| Vol #:
|
| 19
|
|
|
|
|
| C
231
|
| Stoller Farms, Inc.
|
| Vol #:
|
| 19
|
|
|
|
|
| C 232
|
| V. Stram
|
| Vol #:
|
| 19
|
|
|
|
|
| C 233
|
| N. Newman
|
| Vol #:
|
| 19
|
|
| | | | | | | | |
|
| |
|
| EXB 769
|
| Bayer Corporation
|
| Vol #:
|
| 468
|
|
|
|
|
| EXB 770
|
| Bayer Corporation
|
| Vol #:
|
| 468
|
|
|
|
|
| EXB 771
|
| Bayer Corporation
|
| Vol #:
|
| 468
|
|
| |
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| C
2044
|
| Micro ICU Project
|
| Vol #:
|
| 300
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| C
36
|
| Honeywell Chemicals
|
| Vol #:
|
| 6
|
|
|
|
|
| C
37
|
| State of New York Department of Health
|
| Vol #:
|
| 6
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
| C 82
|
| L. Aho
|
| Vol #:
|
| 6
|
|
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
|
|
| C
14
|
| Hill-rom
|
| Vol #:
|
| 2
|
|
|
|
|
| C
15
|
| Advanced Medical Technology Assn (AdvaMed)
|
| Vol #:
|
| 2
|
|
|
|
|
| C
16
|
| Arnot Ogden Medical Center (AOMC)
|
| Vol #:
|
| 2
|
|
| |
|
| 2004D-0369
|
| Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
|
|
|
|
|
| C 1
|
| W. Botwin
|
| Vol #:
|
| 1
|
|
|
|
|
| C 2
|
| A. Kennedy
|
| Vol #:
|
| 1
|
|
|
|
|
| C 3
|
| R. Halfhill
|
| Vol #:
|
| 1
|
|
|
|
|
| C 4
|
| E. Blumenstein
|
| Vol #:
|
| 1
|
|
|
|
|
| C 5
|
| F and M
|
| Vol #:
|
| 1
|
|
|
|
|
| C 6
|
| E. Pool et al.
|
| Vol #:
|
| 1
|
|
|
|
|
| C 7
|
| S. Haines
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 5
|
| Mrs. Diana Barbee
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0438
|
| Guidance for Industry: Use of Material from BSE-Positive Cattle in Animal Feed
|
|
|
|
|
| EC
3
|
| Dr. Reddys's LaboratoriesLimited
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0440
|
| Guidance for Industry on Computerized Systems Used in Clinical Trials
|
|
|
|
|
| EC
4
|
| TAP Pharmaceutical Products Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0460
|
| Guidance for Industry on Listed Drugs, 30-Month Stays, and Approval of ANDAs and 505(b)(2) Applications Under Hatch-Waxman, as Amended by the Medicare Prescription Drug, Improvement, and Modernization
|
|
|
|
|
|
|
|
|
| EC 1
|
| Mr. Bruce DeVoid
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0081
|
| BSE Risk Materials in Foods and Cosmetics
|
|
|
|
|
| C 145
|
| J. Dyne
|
| Vol #:
|
| 13
|
|
